Abrdn Healthcare Investors
HQHFinancial ServicesNASDAQAsset Management
Scan Results
Daily timeframePart of the financial services sector, Abrdn Healthcare Investors (HQH) is listed under Asset Management. The fund invests in public equity markets across the globe.
Market Cap
—
Beta
0.74
P/E (TTM)
5.05
P/E (Fwd)
—
EPS (TTM)
$4.47
EPS (Fwd)
—
ROE
24.2%
ROA
-0.4%
Cash
—
Total Debt
$0
Free CF
—
52W Change
34.3%
Annual Financials
Cash vs Debt
Where HQH stands vs its 150-day and 200-day moving averages
As of the September 1, 2026 close, HQH finished 17.60% above its 150-day moving average ($19.32) and 20.72% above its 200-day moving average ($18.82). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is HQH overbought or oversold?
At the September 1, 2026 close, HQH's RSI(14) was 49.4, in neutral territory (between 30 and 70). The MACD histogram was negative, so short-term momentum leaned bearish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
Abrdn Healthcare Investors carries $0 in total debt, a figure that investors should evaluate relative to the company's earnings power. ROE of 24.2% points to strong capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has grown from -$192.3M (2022) to $99.8M (2025), reflecting a 152% increase over the period.
As with any equity investment, HQH carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence Abrdn Healthcare Investors's trajectory.